John T. Carpenter

6.1k citations
64 papers · 2.7k · 1 hit paper · h-index 21

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Pancreatic and Hepatic Oncology Research
    • Neutropenia and Cancer Infections

Papers in

    • Cancer Treatment and Pharmacology 14
    • Colorectal Cancer Treatments and Studies 5
    • HER2/EGFR in Cancer Research 4
    • Neutropenia and Cancer Infections 4
    • Breast Cancer Treatment Studies 15

John T. Carpenter

53 papers receiving 2.5k citations

John T. Carpenter's Hit Papers

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer 2003 · 921 citations
9210+7+15Years since publication250500750

Peers

John T. Carpenter
Comparison fields: 5 of 142
  • Cancer Research 1.0k
  • Oncology 1.7k
  • Pathology and Forensic Medicine 388
  • Pulmonary and Respiratory Medicine 361
  • Microbiology 8
Replace Shigemitsu Takashima with:
Shigemitsu Takashima Japan
Lukas Hefler Austria
Pax H.B. Willemse Netherlands
Rolf Kåresen Norway
E. Terzoli Italy
Peter J. Rosen United States
John H. Kearsley Australia
H.T. Ford United Kingdom
Bickol N. Mukesh United States
R. Stuart‐Harris Australia
John T. Carpenter relative to Shigemitsu Takashima Japan Shigemitsu Takashima's profile →
Citations per field
00.5×1.5×2.1×
Shigemitsu Takashima · 1×
Citations per year

Countries citing papers authored by John T. Carpenter

Since Specialization
Citations

This map shows the geographic impact of John T. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Carpenter more than expected).

Fields of papers citing papers by John T. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Carpenter. The network helps show where John T. Carpenter may publish in the future.

Co-authors

The 25 scholars most cited alongside John T. Carpenter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John T. Carpenter Line = papers co-authored together John T. Carpenter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
Hit paper breakdown →
2003921
2 1988399
3 1991183
4 1986120
5 197798
6
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy.
199888
7 199179
8 198378
9 198378
10 199277
11 200966
12 200362
13 197542
14 198233
15 201131
16 201029
17 198824
18
Epithelioid hemangioendothelioma: CT manifestations and possible linkage to vinyl chloride exposure.
199124
19 199121
20 197920

About John T. Carpenter

John T. Carpenter is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (14 papers), Breast Lesions and Carcinomas (6 papers), Estrogen and related hormone effects (5 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Neutropenia and Cancer Infections (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.7k citations), Pathology and Forensic Medicine (388 citations), Pulmonary and Respiratory Medicine (361 citations) and Microbiology (8 citations). John T. Carpenter has collaborated with scholars based in United States, Puerto Rico and Pakistan. Frequent co-authors include Robert B. Diasio, Barry Harris, Richard L. Schilsky, James F. Holland, Donald A. Berry, Silvana Martino, Larry Norton, Constance Cirrincione, James N. Ingle and Hyman B. Muss. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Research, Clinical Breast Cancer and Journal of Computer Assisted Tomography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact